Clinical trial
SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor…
NCT00406588 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00406588 |
|---|---|
| Title | SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations |
| Official title | A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of SLV308 as Adjunct Therapy to Levodopa in Patients With Parkinson's Disease Experiencing Motor Fluctuations. |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Advanced Stage Parkinson's Disease |
| Intervention type | Drug |
| Interventions | Levodopa (Pardoprunox), Placebo Comparator |
| Enrollment | 295 |
| Start date | Mar 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Dec 4, 2006 |
| Last update posted | Feb 27, 2015 |
| Countries | Argentina, Brazil, Bulgaria, Canada, Chile, Colombia, Latvia, Lithuania, Peru, Russia, Ukraine, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: